--- title: "Azora Therapeutics surges 23% during regular trading" type: "News" locale: "en" url: "https://longbridge.com/en/news/303973016.md" description: "Azora Therapeutics rose 23.36% to US$4.700. Up 145.81% over six months and down 30.73% from IPO price." datetime: "2026-11-02T14:34:18.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/303973016.md) - [en](https://longbridge.com/en/news/303973016.md) - [zh-HK](https://longbridge.com/zh-HK/news/303973016.md) generator: "portal-rs" --- # Azora Therapeutics surges 23% during regular trading Azora Therapeutics (AZR.US) surged more than **23%** during regular trading to **$4.70**. The stock is up 145.81% over the past six months and down 30.73% from its IPO price. It sits 258.78% above its 52-week low of US$1.310. The Nasdaq Composite is down 2.22% over the past five sessions and up 10.09% year to date. Based on public media reports. AI-generated; not investment advice. ### Related Stocks - [AZR.US](https://longbridge.com/en/quote/AZR.US.md) ## Related News & Research - [Wall St Week Ahead-'Black Friday' brings consumer spending into focus for AI-rocked market](https://longbridge.com/en/news/306395310.md) - [Profit Outlook Raised Could Change The Case For Zeta Global Stock](https://longbridge.com/en/news/306379536.md) - [What Veeva Systems Stock AI Training Integration Means For Shareholders](https://longbridge.com/en/news/306379375.md) - [Wall Street banks set for banner year as Anthropic, SpaceX IPOs generate US$1 billion in fees](https://longbridge.com/en/news/306386521.md) - [Ross Gerber Tells Investors to 'Be Patient' on Anthropic Stock After Post-IPO Slide: ‘That Would Be a Gift’](https://longbridge.com/en/news/306388173.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**